These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20560001)

  • 21. Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
    Blair E; Redwood C; de Jesus Oliveira M; Moolman-Smook JC; Brink P; Corfield VA; Ostman-Smith I; Watkins H
    Circ Res; 2002 Feb; 90(3):263-9. PubMed ID: 11861413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlling load-dependent kinetics of β-cardiac myosin at the single-molecule level.
    Liu C; Kawana M; Song D; Ruppel KM; Spudich JA
    Nat Struct Mol Biol; 2018 Jun; 25(6):505-514. PubMed ID: 29867217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
    Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
    Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-myosin heavy chain gene mutations in familial hypertrophic cardiomyopathy: the usual suspect?
    McNally EM
    Circ Res; 2002 Feb; 90(3):246-7. PubMed ID: 11861410
    [No Abstract]   [Full Text] [Related]  

  • 26. Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy.
    Klos M; Mundada L; Banerjee I; Morgenstern S; Myers S; Leone M; Kleid M; Herron T; Devaney E
    Arch Biochem Biophys; 2017 Feb; 615():53-60. PubMed ID: 28088328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of cardiomyopathy mutation (R97L) in mouse cardiac troponin T on the muscle length-mediated recruitment of crossbridges is modified divergently by α- and β-myosin heavy chain.
    Gollapudi SK; Chandra M
    Arch Biochem Biophys; 2016 Jul; 601():105-12. PubMed ID: 26792537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
    Nanni L; Pieroni M; Chimenti C; Simionati B; Zimbello R; Maseri A; Frustaci A; Lanfranchi G
    Biochem Biophys Res Commun; 2003 Sep; 309(2):391-8. PubMed ID: 12951062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
    Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
    Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.
    Palmiter KA; Tyska MJ; Haeberle JR; Alpert NR; Fananapazir L; Warshaw DM
    J Muscle Res Cell Motil; 2000; 21(7):609-20. PubMed ID: 11227787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
    Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
    Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients.
    García-Castro M; Reguero JR; Batalla A; Díaz-Molina B; González P; Alvarez V; Cortina A; Cubero GI; Coto E
    Clin Chem; 2003 Aug; 49(8):1279-85. PubMed ID: 12881443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype.
    Armel TZ; Leinwand LA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):352-6. PubMed ID: 19913502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region.
    Hougs L; Havndrup O; Bundgaard H; Køber L; Vuust J; Larsen LA; Christiansen M; Andersen PS
    Eur J Hum Genet; 2005 Feb; 13(2):161-5. PubMed ID: 15483641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Kärkkäinen S; Peuhkurinen K; Nieminen MS; Laakso M; ; Kuusisto J
    Ann Med; 2014 Sep; 46(6):424-9. PubMed ID: 24888384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three novel mutations in exon 21 encoding beta-cardiac myosin heavy chain.
    Moric E; Mazurek U; Połońska J; Domal-Kwiatkowska D; Smolik S; Kozakiewicz K; Tendera M; Wilczok T
    J Appl Genet; 2003; 44(1):103-9. PubMed ID: 12590187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
    Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
    J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fetus with hypertrophic cardiomyopathy, restrictive, and single-ventricle physiology, and a beta-myosin heavy chain mutation.
    Hinton RB; Michelfelder EC; Marino BS; Bove KE; Ware SM
    J Pediatr; 2010 Jul; 157(1):164-6. PubMed ID: 20394946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.